Table 2 VTE risk factors & contraindications to prophylaxis
Risk factors & contraindications | Pre intervention (n = 150) | Post intervention (n = 150) | P Value |
|---|---|---|---|
High-risk of VTE | 126 (84) | 116 (77) | 0.14^ |
Risk factors | |||
Ischaemic stroke | 7 (4.7) | 3 (2) | 0.19^ |
History of VTE | 15 (10) | 18 (12) | 0.58^ |
Active cancer | 4 (2.7) | 4 (2.7) | 1.0^ |
Decompensated heart failure | 42 (28) | 29 (19) | 0.7^ |
Acute on chronic lung disease | 10 (6.7) | 10 (6.7) | 1.0^ |
Age > 60 years and immobile | 107 (71) | 108 (72) | 0.89^ |
Acute inflammatory disease | 6 (4) | 1 (0.7) | 0.5^ |
Multiple additional risk factors | 21 (14) | 10 (6.7) | 0.33^ |
Additional risk factors | |||
Immobility (<60 years) | 1 (0.7) | 1 (0.7) | 0.98^ |
Familial history of VTE | 1 (0.7) | 0 (0) | 0.31^ |
Oestrogen therapy | 2 (1.4) | 1 (0.7) | 0.55^ |
Obesity | 10 (6.8) | 7 (4.7) | 0.43^ |
Thrombophilia | 1 (0.7) | 0 (0) | 0.313^ |
Active inflammation | 6 (4.1) | 2 (1.4) | 0.09^ |
Contraindications | 48 (32) | 49 (32.7) | 0.15^ |
Active bleeding | 5 (3.3) | 5 (3.3) | 1.0^ |
High risk of bleeding | 5 (3.3) | 7 (4.7) | 0.55^ |
Severe hepatic disease | 1 (0.7) | 0 | 0.31^ |
Heparin induced thrombocytopenia | 0 (0) | 0 (0) | |
Current anticoagulation | 41 (27.3) | 38 (25.3) | 0.69^ |
Other contraindication | 0 (0) | 2 (1.3) | 0.15^ |